MA Bradley-Whitman

First name:
MA
Last name:
Bradley-Whitman
Bradley-Whitman, M. A., Roberts, K. N., Abner, E. L., Scheff, S. W., Lynn, B. C., & Lovell, M. A. A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury. Brain Injury, 32(3), 363-380. https://doi.org/10.1080/02699052.2017.1418907 (Original work published 2018)
View
Bradley-Whitman, M. A., Abner, E., Lynn, B. C., & Lovell, M. A. A Novel Plasma Based Biomarker of Alzheimer's Disease. Journal Of Alzheimer's Disease : Jad, 47(3), 761-71. https://doi.org/10.3233/JAD-150183 (Original work published 2015)
View
Bradley-Whitman, M. A., Timmons, M. D., Beckett, T. L., Murphy, M. P., Lynn, B. C., & Lovell, M. A. (2014). Nucleic acid oxidation: an early feature of Alzheimer's disease. Journal Of Neurochemistry, 128(2), 294-304. https://doi.org/10.1111/jnc.12444
View
Ellison, E. M., Bradley-Whitman, M. A., & Lovell, M. A. (2017). Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects. Journal Of Molecular Neuroscience : Mn, 63(2), 185-197. https://doi.org/10.1007/s12031-017-0969-y
View
Bradley-Whitman, M. A., & Lovell, M. A. (2015). Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Archives Of Toxicology, 89(7), 1035-44. https://doi.org/10.1007/s00204-015-1517-6
View
Bradley-Whitman, M. A., & Lovell, M. A. (2013). Epigenetic changes in the progression of Alzheimer's disease. Mechanisms Of Ageing And Development, 134(10), 486-95. https://doi.org/10.1016/j.mad.2013.08.005
View